Tornier to Present at the 31stAnnual J.P. Morgan Healthcare Conference
AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NAS: TRNX) , a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Interim President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the 31st Annual J.P. Morgan Healthcare Conference.
The Company's presentation is scheduled for Monday, January 7, at 11:30 a.m. pacific time at the Westin St. Francis Hotel in San Francisco, CA.
The presentation will be webcast live on the Investor Relations section of the Company's website at www.tornier.com. For those who are not available to listen to the live webcast, a replay will be archived for one year.
Tornier is a global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's broad offering of over 100 product lines includes joint replacement, trauma, sports medicine, and ortho-biologic products through Tornier and OrthoHelix brands to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier's "Specialists Serving Specialists" philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopaedic technology stemming from its close collaboration with orthopaedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit www.tornier.com, or OrthoHelix, visit www.orthohelix.com.
Chief Financial Officer
KEYWORDS: United States Europe North America Netherlands California
The article Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.